emitefur has been researched along with Experimental Neoplasms in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Taguchi, T | 1 |
| Hiraoka, M; Hirohashi, M; Miyauchi, S; Murata, R; Oya, N; Sasai, K; Shibamoto, Y; Takagi, T | 1 |
| Hirohashi, M; Miyauchi, S; Murata, R; Oya, N; Sasai, K; Shibamoto, Y; Shibata, T; Takagi, T; Takahashi, M | 1 |
| Fujii, S; Fukushima, M; Imaoka, T; Kimura, A; Kimura, Y; Ohshimo, H; Shimamoto, Y; Shirasaka, T; Utsunomiya, T | 1 |
| Fujii, S; Fujita, F; Fujita, M; Fukushima, M; Shirasaka, T; Taguchi, T | 1 |
1 review(s) available for emitefur and Experimental Neoplasms
| Article | Year |
|---|---|
[Development of fluorinated pyrimidines in Japan].
Topics: Animals; Antineoplastic Agents; Clinical Trials as Topic; Deoxycytidine; Drug Combinations; Fluorodeoxyuridylate; Fluorouracil; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Neoplasms; Neoplasms, Experimental; Oxonic Acid; Pyridines; Rats; Tegafur | 1993 |
4 other study(ies) available for emitefur and Experimental Neoplasms
| Article | Year |
|---|---|
The combined antitumour effect of a new 5-fluorouracil derivative, BOF-A2, and radiation in vivo.
Topics: Animals; Antineoplastic Agents; Combined Modality Therapy; Fluorouracil; Mice; Mice, Inbred C3H; Neoplasms, Experimental | 1996 |
Combined effect of clinically relevant doses of emitefur, a new 5-fluorouracil derivative, and radiation in murine tumours.
Topics: Animals; Antineoplastic Agents; Body Weight; Carcinoma, Squamous Cell; Combined Modality Therapy; Drug Administration Schedule; Female; Fluorouracil; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Tumor Stem Cell Assay | 1996 |
[Metabolic characteristics and antitumor activity of BOF-A2, a new 5-fluorouracil derivative].
Topics: Animals; Antineoplastic Agents; Female; Fluorouracil; Male; Mammary Neoplasms, Experimental; Mice; Neoplasms, Experimental; Rats | 1990 |
[Antitumor activity and metabolism of BOF-A2, a new 5-fluorouracil derivative, with human cancers xenografted in nude mice].
Topics: Administration, Oral; Animals; Antineoplastic Agents; Colorectal Neoplasms; Fluorouracil; Humans; Liver; Mice; Mice, Nude; Microsomes; Neoplasm Transplantation; Neoplasms, Experimental; Pancreatic Neoplasms; Stomach Neoplasms | 1990 |